Menu

Xilio Therapeutics, Inc. XLO

Full chart Compare
Set alert

Price alert · XLO

All alert types
9.00 USD +0.37 (+4.29%)

At closeNov 9, 2026, 6:15 PM EST

8.82 -0.18 -2.00%

After hours · Nov 9, 6:15 PM ET

8.57 Day range 9.00
6.47 52-week range 11.75
YTD
+0.45%
1 year
-20.35%

Revenue & Expenses

Other Income → Expenses: $6.95MExpenses → Selling, General & Admin: $29.71MExpenses → Research & Development: $56.04MGross Profit → Expenses: $43.77MRevenue → Gross Profit: $43.77MNet Loss → Expenses: $35.04MOther Income$6.95MGross Profit$43.77MNet Loss$35.04MExpenses$85.75MSelling, General & Admin$29.71MResearch & Development$56.04MRevenue$43.77M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

XLO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
43.77M6.34M000
43.77M6.34M000
43.77M6.34M000
85.75M66.93M79.13M89.15M75.04M
56.04M41.21M52.14M59.20M51.19M
29.71M24.78M27.00M29.95M23.86M
-41.98M-60.58M-79.13M-89.15M-75.04M
-35.04M-58.24M-76.40M-88.22M-75.80M
-35.04M-58.24M-76.40M-88.22M-75.80M
-35.04M-58.24M-76.40M-88.22M-75.80M
-35.04M-58.24M-76.40M-88.22M-75.80M
-4.19-15.24-38.90-45.10-189.00
-4.19-15.24-38.90-45.10-189.00
-4.19-15.24-38.90-45.10-189.00
-35.04M-58.24M-76.40M-88.22M-75.80M
-35.04M-58.24M-76.40M-88.22M-75.80M
8.36M3.82M1.96M1.96M400.45K
8.36M3.82M1.96M1.96M400.45K